New Ray Medicine International Holding Limited (HKG:6108)
Hong Kong · Delayed Price · Currency is HKD
0.2310
+0.0090 (4.05%)
At close: May 12, 2026
Revenue by Segment
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Provision of Marketing and Promotion Services of Drugs | | | 7.30M | 6.02M | 5.76M | 4.52M | 3.98M | | | |
Provision of Marketing and Promotion Services of Drugs Growth | | | 21.36% | 4.48% | 27.41% | 13.57% | -49.67% | | | |
Distribution and Trading of Pharmaceutical Products | | | 42.85M | 83.75M | 329.62M | 128.69M | 114.65M | | | |
Distribution and Trading of Pharmaceutical Products Growth | | | -48.84% | -74.59% | 156.13% | 12.25% | -68.55% | | | |
| | | 50.15M | 89.77M | 335.38M | 133.21M | 118.63M | | | |
| | | -44.13% | -73.23% | 151.76% | 12.29% | -68.15% | | | |
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
People's Republic of China (PRC) | | | 50.15M | 89.77M | 335.38M | 133.21M | 118.63M | | | |
People's Republic of China (PRC) Growth | | | -44.13% | -73.23% | 151.76% | 12.29% | -68.15% | | | |
| | | 50.15M | 89.77M | 335.38M | 133.21M | 118.63M | | | |
| | | -44.13% | -73.23% | 151.76% | 12.29% | -68.15% | | | |
Source: S&P Global Market Intelligence.
